loader2
Partner With Us NRI

Jul 23, 2024


Category

Equity

AUM (Cr.)

7,404.21

Exit Load (%)

0.00

Min Inv Lumpsum

5,000

Expense Ratio

1.82

Sharpe Ratio

22.86

Beta Ratio

0.00

Fund Manager

Sailesh Raj Bhan

Inception Date

Jun 05, 2004

Risk Level

Very High

Investment Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Pharma Fund (Bonus) 5.27 14.62 41.13 14.18 27.13 21.02
Benchmark - S&P BSE Healthcare 14.73 38.57 53.75 13.45 1.76 0
Category Average - BEST EQUITY PERFORMERS 2.82 21.7 42.55 20.8 22.78 21.05
Category Rank 5/5 6/5 7/5 8/5 7/5 5/5
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Nippon India Taiwan Equity Fund (IDCW) 10.7670 3.93 16.04 0.00 0.00 414.11 2.43 500.00 invest
Nippon India Taiwan Equity Fund (G) 10.7670 3.93 16.04 0.00 0.00 414.11 2.43 500.00 invest
ICICI Pru FMCG Fund - (G) 525.5600 2.29 16.08 20.71 17.63 1,612.97 2.18 5,000.00 invest
ICICI Pru FMCG Fund - (IDCW) 105.5700 2.29 16.08 20.71 17.63 1,612.97 2.18 5,000.00 invest
Quant BFSI Fund - Regular (IDCW) 17.0394 -1.82 60.24 0.00 0.00 617.87 2.32 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Jun 30, 2024 997.12 13.47 4.18
Equity-Divi`s Lab. Jun 30, 2024 620.89 8.39 15.25
Equity-Lupin Jun 30, 2024 568.07 7.67 2.45
Equity-Cipla Jun 30, 2024 459.05 6.20 2.32
Equity-Dr Reddy`s Labs Jun 30, 2024 448.18 6.05 40.69
Equity-Apollo Hospitals Jun 30, 2024 401.33 5.42 5.93
Equity-Zydus Lifesci. Jun 30, 2024 290.03 3.92 7.38
Equity-Gland Pharma Jun 30, 2024 273.73 3.70 -12.50
Equity-Abbott India Jun 30, 2024 238.64 3.22 6.71
Equity-Vijaya Diagnost. Jun 30, 2024 236.74 3.20 -7.95

latest news

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 July 2024 as the record date for ...

Jul 10, 2024 09:56

Nippon India MF Announces change in scheme name

Nippon India Mutual Fund has announced change in scheme name under the foll...

Jun 15, 2024 12:10

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 13 June 2024 as the record date for ...

Jun 11, 2024 09:37

Nippon MF Announces change in scheme name

Nippon India Mutual Fund has announced change in scheme name under the foll...

Jun 01, 2024 14:23

Nippon Mutual Fund Announces change in benchmark under its schemes

Nippon Mutual Fund has announced change the benchmark index for the followi...

Jun 01, 2024 13:38

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 14 May 2024 as the record date for d...

May 10, 2024 09:09

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Pharma Fund (Bonus)
Contact Persone : Sailesh Raj Bhan
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com